Search company, investor...

Founded Year



Other Investors | Alive

About Calpyso Medical

Calypso Medical provides technologies in the radiation oncology market

Headquarters Location

2101 Fourth Avenue 4th & Blanchard Building, Suite 500

Seattle, Washington, 98121,

United States



Calpyso Medical Frequently Asked Questions (FAQ)

  • When was Calpyso Medical founded?

    Calpyso Medical was founded in 1999.

  • Where is Calpyso Medical's headquarters?

    Calpyso Medical's headquarters is located at 2101 Fourth Avenue, Seattle.

  • What is Calpyso Medical's latest funding round?

    Calpyso Medical's latest funding round is Other Investors.

  • Who are the investors of Calpyso Medical?

    Investors of Calpyso Medical include RiverVest Venture Partners, Mosaix Ventures, Earlybird Venture Capital, Kaiser Permanente Ventures and Frazier Healthcare Partners.

  • Who are Calpyso Medical's competitors?

    Competitors of Calpyso Medical include CivaTech Oncology, Augmenix, Pharmacyclics, Pathwork Diagnostics, Proterixbio and 7 more.


Compare Calpyso Medical to Competitors

Radiation Shield Technologies

Radiation Shield Technologies specializes in the research, design, and production of personal protection systems within the safety and defense industry. The company offers products such as full body suits, blankets, and tents made from a patented, lightweight, non-toxic, and lead-free fabric called Demron, which is designed to protect individuals from ionizing and nuclear radiation. These products are aimed at providing safety for users in environments where radiological or nuclear hazards are present. It is based in Coral Gables, Florida.

CivaTech Oncology Logo
CivaTech Oncology

Civatech Oncology is a medical device company focused on the development of polymer-based devices that treat cancer using localized, low-dose-rate radiation. The company's fabrication methods allow for the encapsulation of radioactive materials into polymer structures. These polymer-based brachytherapy devices offer physicians treatment options for tumors with low-dose-rate brachytherapy. CivaTech Oncology was founded in 2006 and is based in Durham, North Carolina.

Smart Animal Logo
Smart Animal

Smart Animal is a research company focused on personalized medicine within the immunotherapy and diagnostics sectors. They offer a platform-oriented device that modifies or enhances the body's immune response to target diseases, administered in outpatient settings. The company's technology is used for labeling antibodies for imaging and targeted drug delivery in cancer treatment and can be applied to autoimmune disorders and veterinary use. It was founded in 2006 and is based in Marlborough, Massachusetts.

LUX biotechnology

LUX biotechnology is a company focused on the extraction of bioactives from microalgae, operating in the biotechnology sector with applications in nutrition and skincare. The company offers high-quality nutritional supplements and skincare products derived from microalgae, designed to improve wellbeing while adhering to environmentally sustainable practices. LUX biotechnology utilizes patented photobioreactors and innovative cultivation strategies to produce unique bioactive compounds for their products. It is based in United Kingdom.

Swissray International

Swissray has been recognized as the industry's true pioneer in the design, manufacture and marketing of direct digital Radiography ddR technology. Delivering high quality radiographic images in just seconds, Swissray's single detector technology aims to improve overall productivity, and lowers the cost of general radiography in comparison to conventional or computed radiography.


i-Nalysis builds and sells a palm-sized X-ray Fluorescence (XRF) unit.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.